@ EddieB.
I would love to contradicts you, and I am trying very hard to find a weakness in your analysis, unfortunately for my investment I am afraid , I can t…! as I understand it, the only way for TM shares to go up is the confirmation from the FiD that the promised technology will be actual as an industrial process and maybe in the future a collaboration with the French ( I doubt they need a Norwegian company but since the French project apparently wants to include several European key players being finance by European funding…who knows?..).
The France 2030 investment plan: ( ORANO MED )
«France 2030 is unprecedented in its scale: €54 billion is being invested so that our businesses, our schools, our universities and our research organizations fully succeed with their transitions in these strategic sectors. The challenge is to enable them to respond in a competitive way to the world’s future ecological and attractiveness challenges, and to showcase the future champions of our sectors of excellence. France 2030 is defined by two overarching objectives, which will see 50% of expenses given over to the decarbonization of the economy, and 50% to emerging key players, those at the forefront of innovation, without neglecting the environment (in the sense of the “Do No Significant Harm” principle).
France 2030 is being implemented collectively: designed and deployed in consultation with economic, academic, local and European key players to establish strategic guidelines and decisive action. Project holders are invited to submit their entries via the current application process, which is a demanding and selective one, to benefit from state support.
France 2030 is being led by the French General Secretariat for Investment, in charge of France 2030, on behalf of the Prime Minister, and in partnership with the relevant government ministries.
France 2030 is being implemented by the French National Research Agency (ANR), the French Agency for Ecological Transition (ADEME), Bpifrance and the Caisse des Dépôts et consignation (CDC).»